SEC Form 4 · accession 0001179110-18-007973
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Goldstein
Director
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 5:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $50.90 | May 31, 2018 | A | 4,082 | A | — | May 31, 2028 | Common Stock | 4,082 | 4,082 | D |
| Restricted Stock UnitsF3,F1 | — | May 31, 2018 | A | 1,965 | A | — | — | Common Stock | 1,965 | 1,965 | D |
Explanation of responses
- F1The restricted stock units vest in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
- F2The option vests in full on the earlier of (i) May 31, 2019 and (ii) the day immediately preceding the issuer's 2019 annual meeting of stockholders.
- F3Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.